查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1565716

全身麻醉藥物市場，按類型、給藥途徑、手術類型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

General Anesthesia Drugs Market, By Type, By Route Of Administration, By Surgery Type, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年全身麻醉藥物市場規模預估為51.142億美元，2024年至2032年複合年成長率為4.00%。

全身麻醉藥品市場-市場動態

微創手術 (MIS) 治療慢性疾病的頻率不斷增加

慢性病盛行率的上升正在推動 MIS 全身麻醉藥物的成長。對慢性病手術治療的需求增加，直接導致尋求手術的患者數量增加，從而推動了對安全有效麻醉藥物的需求增加。 MIS 技術的採用增加，通常會縮短復健時間並縮短住院時間，是醫​​療保健提供者增加使用的重要驅動力。這一趨勢鼓勵開發和採用先進的全身麻醉藥物，以提高患者在手術過程中的舒適度和安全性，最終有助於市場的擴大，以滿足對高效手術解決方案不斷成長的需求。例如，《微創外科雜誌》（MIS期刊）發表的一篇文章稱，微創外科（MIS）領域的論文被接受並發表了58篇，其中包括37篇綜述、10篇原創文章和一篇系統綜述。這項系統研究針對經導管主動脈瓣植入手術的連合對齊進行電腦輔助品質評估，這可能是緩解肝細胞癌冠狀動脈再通和重做經導管主動脈瓣植入(TAVI) 的新領域。

全身麻醉藥物市場 - 關鍵見解

我們的研究分析師估計，從 2024 年到 2032 年，全球市場將以 4.00% 的複合年成長率發展。

2023 年，根據類型細分，異丙酚產業擁有最高的市場佔有率。

根據給藥途徑細分，靜脈注射 (IV) 給藥途徑細分市場在 2023 年佔據主導地位。

根據手術類型細分，預計膝關節和髖關節置換術領域將在預測期內引領市場。

從地區來看，2023 年，北美地區的收入最高。

全身麻醉藥物市場-細分分析：

全球車載聚光燈市場分為五類：類型、給藥途徑、手術類型、最終用戶和地區。

市場依類型分為四個部分：異丙酚、地氟烷、七氟烷和其他。 2023年，異丙酚類別主導市場，預計在預測期內將以最快的複合年成長率成長。異丙酚以其快速起效和恢復時間而聞名，可提高患者舒適度和手術效率。它經常用於麻醉誘導和維持，為各種外科和診斷操作提供了適應性強的選擇。該藥物良好的藥物動力學特徵，包括半衰期短和代謝快，增加了它對麻醉科醫師的吸引力。

市面上依給藥途徑分為兩種：吸入型和靜脈注射型。靜脈注射 (IV) 行業的收入佔有率最高。這種成長趨勢主要是由許多重要變數推動的，包括靜脈麻醉劑傳遞、功效和便利性的進步。靜脈麻醉因其起效快、給藥控制精確而受到青睞，這對於處理複雜的外科手術和保障病人安全至關重要。即時修改劑量的能力使麻醉師能夠根據患者的需求和手術要求量身訂做麻醉深度。

全身麻醉藥物市場 - 地理洞察

從地理來看，該市場包括北美、亞太地區、中東以及非洲、拉丁美洲、歐洲。這些區域根據哪些國家帶來業務進一步分類。

受一系列關鍵變數的推動，例如慢性病的高盛行率、技術進步和重要的醫療基礎設施，北美全身麻醉藥品市場將在 2023 年佔據主導地位。心血管疾病和癌症等慢性疾病的發生率增加，經常需要進行外科手術，這增加了全身麻醉的需求。

由於醫療保健成本上升、手術需求增加以及技術進步，人口不斷成長，亞太地區全身麻醉藥品市場正在迅速擴大。亞太地區人口眾多且多樣化，慢性病發生率不斷上升以及外科手術的需求增加，都導致全身麻醉的需求增加。中國和印度政府正在大力投資醫療基礎設施和醫療技術，這正在推動市場成長。

全身麻醉藥品市場-競爭格局：

全身麻醉藥品市場的特點是由幾個主要參與者組成，包括輝瑞公司、Paion AG、B. Braun Melsungen 和Avet Pharmaceuticals Inc. 等老牌製藥公司，這些公司憑藉龐大的產品線和順暢的配銷通路佔據市場主導地位。這些企業也加大了研發投入。在小型公司和學名藥製造商爭奪市場佔有率的過程中，低成本版本也越來越受到重視。在對安全、有效麻醉的需求不斷增加的情況下，隨著公司努力增強其產品供應實力並擴大其市場影響力，戰略聯盟、合併和收購如雨後春筍般湧現。

最新進展：

2024 年 4 月，百特增加了在美國的藥品供應，推出了鹽酸羅哌卡因注射液 (USP)。這種新藥採用方便、即用型、單劑量輸液袋包裝。

目錄

第 1 章：全身麻醉藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的全身麻醉藥物市場片段
    • 依給藥途徑分類的全身麻醉藥物市場片段
    • 按手術類型分類的全身麻醉藥物市場片段
    • 最終使用者的全身麻醉藥物市場片段
    • 按國家/地區分類的全身麻醉藥物市場片段
    • 按地區分類的全身麻醉藥物市場片段
  • 競爭洞察

第 3 章：全身麻醉藥物主要市場趨勢

  • 全身麻醉藥物市場促進因素
    • 市場促進因素的影響分析
  • 全身麻醉藥品市場限制
    • 市場限制影響分析
  • 全身麻醉藥物市場機會
  • 全身麻醉藥物市場未來趨勢

第 4 章：全身麻醉藥品產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：全身麻醉藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：全身麻醉藥物市場格局

  • 2023 年全身麻醉藥物市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：全身麻醉藥物市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 異丙酚
    • 地氟烷
    • 七氟醚
    • 其他

第 8 章：全身麻醉藥物市場 - 依給藥途徑

  • 概述
    • 按管理途徑分類的細分市場佔有率分析
    • 吸入
    • 靜脈

第 9 章：全身麻醉藥物市場 - 依手術類型

  • 概述
    • 按手術類型分類的細分市場佔有率分析
    • 膝關節和髖關節置換術
    • 癌症手術
    • 心臟手術
    • 一般外科

第 10 章：全身麻醉藥物市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 門診手術中心
    • 醫院

第 11 章：全身麻醉藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美全身麻醉藥物主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按手術類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲全身麻醉藥物主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按手術類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區全身麻醉藥物主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模與預測（依手術類型）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲全身麻醉藥物主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按手術類型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲全身麻醉藥物主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（依手術類型）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 全身麻醉藥品產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Paion AG
    • B. Braun Melsungen
    • Avet Pharmaceuticals Inc
    • Baxter International Inc.
    • Abbott Laboratories
    • Fresenius SE and Co. KGaA
    • Abbvie Inc,
    • AstraZeneca plc
    • Hikma Pharmaceuticals plc
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3920

REPORT HIGHLIGHT

General Anesthesia Drugs market size was evaluated at USD 5,114.2 million in 2023, rising at a CAGR of 4.00% from 2024 to 2032.

General anesthetic drugs are essential for establishing and maintaining a state of unconsciousness without pain during a variety of surgical operations. These medications, which are delivered intravenously or via inhalation, are utilized in a variety of surgeries, including cardiac, orthopedic, oncology, and gastrointestinal procedures.

General Anesthesia Drugs Market- Market Dynamics

Increasing Frequency of Chronic Illnesses Treated with Minimally Invasive Surgery (MIS)

Higher prevalence rates of chronic diseases are driving the growth of MIS general anesthesia drugs. A greater demand for surgical treatment in chronic diseases translates directly into a higher number of patients seeking surgery, thus fueling increased demand for safe and effective anesthesia drugs. Increased adoption of MIS techniques, which often result in quicker recovery times and shorter hospital stays, are an important driver of increased use by healthcare providers. This trend encourages the development and adoption of advanced general anesthesia drugs that enhance patient comfort and safety during procedures, ultimately contributing to the expansion of the market in response to the growing demand for efficient surgical solutions. For instance, an article published in the Minimal Invasive Surgery Journal (MIS journal) stated that 58 papers on minimal invasive surgery (MIS) were accepted and published, including 37 reviews, 10 original articles, and one systematic review. The systematic study addressed computer-assisted quality evaluation for surgeries commissural alignment in transcatheter aortic valve implantation, which may be a new frontier to ease coronary re-access and redo transcatheter aortic valve implantation (TAVI) in hepatocellular carcinoma.

General Anesthesia Drugs Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of 4.00% from 2024 to 2032.

In 2023, the propofol sector had the highest market share based on Type segmentation.

Based on Route Of Administration segmentation, The intravenous (IV) Route Of Administration segment dominated the market in 2023.

The knee and hip replacement sector is expected to lead the market over the projection period, according to Surgery Type segmentation.

On the basis of region, in 2023, North America generated the highest revenue.

General Anesthesia Drugs Market- Segmentation Analysis:

The global vehicle-mounted spotlights market is divided into five categories: Type, Route Of Administration, Surgery Type, End-user, and region.

The market is classified into four segments based on the type: Propofol, Desflurane, Sevoflurane, and Others. In 2023, the propofol category dominated the market and is predicted to grow at the quickest CAGR over the forecast period. Propofol is known for its rapid onset and recovery times, which improve patient comfort and procedural efficiency. It is frequently used for anesthesia induction and maintenance, giving it an adaptable option for a wide range of surgical and diagnostic operations. The agent's good pharmacokinetic profile, which includes a short half-life and quick metabolism, adds to its appeal among anesthesiologists.

The market is separated into two types based on the route of administration: inhalation and intravenous. The intravenous (IV) sector had the highest revenue share. This growing trend is primarily driven by a number of significant variables, including advances in IV anesthetic delivery, efficacy, and convenience. IV anesthesia is favored because of its quick onset of effect and precise control over drug administration, which are critical for handling complex surgical operations and guaranteeing patient safety. The ability to modify dosage in real time enables anesthesiologists to tailor anesthetic depth based on the patient's demands and the surgical requirements.

General Anesthesia Drugs Market- Geographical Insights

Geographically, this market encompasses North America, Asia Pacific, the Middle East, and Africa, Latin America, Europe. These zones are further split based on which countries bring business.

The North American general anesthesia medicines market dominated in 2023, driven by a number of crucial variables, such as the high prevalence of chronic diseases, technological improvements, and significant healthcare infrastructure. The increased frequency of chronic illnesses such as CVD and cancer, which frequently necessitate surgical procedures, increases the demand for general anesthesia.

The Asia Pacific general anesthetic medicines market is quickly expanding as a result of rising healthcare costs, a growing population with increased surgical needs, and technological improvements. The large and diverse population of APAC, as well as the rising frequency of chronic illnesses and the requirement for surgical operations, all contribute to increased need for general anesthesia. Governments in China and India are investing heavily in healthcare infrastructure and medical technology, which is driving market growth.

General Anesthesia Drugs Market- Competitive Landscape:

The general anesthesia drugs market is characterized by a few main players, including established pharmaceutical companies such as Pfizer Inc., Paion AG, B. Braun Melsungen, and Avet Pharmaceuticals Inc., which dominate the market with a massive product line and smooth distribution channels. These players have also increased their investments in R&D. Low-cost versions are also gaining prominence in the quest for market share by smaller firms and generic manufacturers. Strategic alliances, mergers, and acquisitions mushroom as companies strive to build strength in their product offerings and increase their reach into the marketplace at a time when demand for safe, effective anesthesia is ever-increasing.

Recent Developments:

In April 2024, Baxter increased their pharmaceutical offering in the United States with the introduction of Ropivacaine Hydrochloride Injection, USP. This new medicine is packaged in a convenient, ready-to-use, single-dose infusion bag.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERAL ANESTHESIA DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Paion AG
  • B. Braun Melsungen
  • Avet Pharmaceuticals Inc
  • Baxter International Inc.
  • Abbott Laboratories
  • Fresenius SE and Co. KGaA
  • Abbvie Inc,
  • AstraZeneca plc
  • Hikma Pharmaceuticals plc
  • Others

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Propofol
  • Desflurane
  • Sevoflurane
  • Others

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Inhalation
  • Intravenous

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY SURGERY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Knee and hip replacements
  • Cancer surgery
  • Heart surgeries
  • General surgery

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Ambulatory surgical centers
  • Hospital

GLOBAL GENERAL ANESTHESIA DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. General Anesthesia Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. General Anesthesia Drugs Market Snippet by Type
    • 2.1.2. General Anesthesia Drugs Market Snippet by Route Of Administration
    • 2.1.3. General Anesthesia Drugs Market Snippet by Surgery Type
    • 2.1.4. General Anesthesia Drugs Market Snippet by End-user
    • 2.1.5. General Anesthesia Drugs Market Snippet by Country
    • 2.1.6. General Anesthesia Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. General Anesthesia Drugs Key Market Trends

  • 3.1. General Anesthesia Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. General Anesthesia Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. General Anesthesia Drugs Market Opportunities
  • 3.4. General Anesthesia Drugs Market Future Trends

4. General Anesthesia Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. General Anesthesia Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. General Anesthesia Drugs Market Landscape

  • 6.1. General Anesthesia Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. General Anesthesia Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Propofol
    • 7.1.3. Desflurane
    • 7.1.4. Sevoflurane
    • 7.1.5. Others

8. General Anesthesia Drugs Market - By Route Of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route Of Administration, 2023 & 2032 (%)
    • 8.1.2. Inhalation
    • 8.1.3. Intravenous

9. General Anesthesia Drugs Market - By Surgery Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Surgery Type, 2023 & 2032 (%)
    • 9.1.2. Knee and hip replacements
    • 9.1.3. Cancer surgery
    • 9.1.4. Heart surgeries
    • 9.1.5. General surgery

10. General Anesthesia Drugs Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 10.1.2. Ambulatory surgical centers
    • 10.1.3. Hospital

11. General Anesthesia Drugs Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. General Anesthesia Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. General Anesthesia Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. General Anesthesia Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. General Anesthesia Drugs Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. General Anesthesia Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Surgery Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- General Anesthesia Drugs Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Paion AG
    • 12.2.3. B. Braun Melsungen
    • 12.2.4. Avet Pharmaceuticals Inc
    • 12.2.5. Baxter International Inc.
    • 12.2.6. Abbott Laboratories
    • 12.2.7. Fresenius SE and Co. KGaA
    • 12.2.8. Abbvie Inc,
    • 12.2.9. AstraZeneca plc
    • 12.2.10. Hikma Pharmaceuticals plc
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us